Increased platelet CD63 and P-selectin expression persist in atherosclerotic ischemic stroke

被引:27
作者
Cha, JK
Jo, WS
Shin, HC
Bae, HR
Ho, JM
Kim, JW
机构
[1] Dong A Univ, Coll Med, Dept Neurol, Pusan, South Korea
[2] Dong A Univ, Coll Med, Inst Med Sci, Pusan, South Korea
关键词
D O I
10.1080/09537100310001644024
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Platelet activation is an important process in the pathogenesis of atherothrombosis. However, the serial changes of platelet activation in atherosclerotic ischemic stroke have not been determined. In this study, we measured serially platelet expression of CD63 and P-selectin and platelet aggregability to ADP and collagen. Measurements were made 24 and 72 h and 7 and 90 days after the ischemic event in 29 patients with atherosclerotic ischemic stroke. Platelet aggregability was significantly decreased after 72 h compared to that at 24 h of stroke onset. However, platelet CD63 and P-selectin expression remained high even 90 days after the events. These findings suggest that platelet hyperactivation in atherosclerotic ischemic stroke may be sustained for a considerable period.
引用
收藏
页码:3 / 7
页数:5
相关论文
共 31 条
[1]   CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]   Benefit of ADP receptor antagonists in atherothrombotic patients: New evidence [J].
Bogousslavsky, J .
CEREBROVASCULAR DISEASES, 2001, 11 :5-10
[3]   Serial measurement of surface expressions of CD63, P-selectin and CD40 ligand on platelets in atherosclerotic ischernic stroke - A possible role of CD40 ligand on platelets in atherosclerotic ischemic stroke [J].
Cha, JK ;
Jeong, MH ;
Jang, JY ;
Bae, HR ;
Lim, YJ ;
Kim, JS ;
Kim, SH ;
Kim, JW .
CEREBROVASCULAR DISEASES, 2003, 16 (04) :376-382
[4]   Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel [J].
Cha, JK ;
Jeong, MH ;
Lee, KM ;
Bae, HR ;
Lim, YJ ;
Park, KW ;
Cheon, SM .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2002, 14 (02) :145-150
[5]   Characterization of the effects of isoprostanes on platelet aggregation in human whole blood [J].
Cranshaw, JH ;
Evans, TW ;
Mitchell, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (08) :1699-1706
[6]   THROMBOSIS AND ACUTE CORONARY-ARTERY LESIONS IN SUDDEN CARDIAC ISCHEMIC DEATH [J].
DAVIES, MJ ;
THOMAS, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (18) :1137-1140
[7]   Prominent role of P-selectin in the development of advanced atherosclerosis in apoE-deficient mice [J].
Dong, ZM ;
Brown, AA ;
Wagner, DD .
CIRCULATION, 2000, 101 (19) :2290-2295
[8]   Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia [J].
Garlichs, CD ;
Kozina, S ;
Fateh-Moghadam, S ;
Tomandl, B ;
Stumpf, C ;
Eskafi, S ;
Raaz, D ;
Schmeisser, A ;
Yilmaz, A ;
Ludwig, J ;
Neundörfer, B ;
Daniel, WG .
STROKE, 2003, 34 (06) :1412-1417
[9]   Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets [J].
Garlichs, CD ;
Eskafi, S ;
Raaz, D ;
Schmidt, A ;
Ludwig, J ;
Herrmann, M ;
Klinghammer, L ;
Daniel, WG ;
Schmeisser, A .
HEART, 2001, 86 (06) :649-655
[10]   Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans [J].
Heesch, CM ;
Wilhelm, CR ;
Ristich, J ;
Adnane, J ;
Bontempo, FA ;
Wagner, WR .
HEART, 2000, 83 (06) :688-695